U.S. markets closed

IRadimed Corporation (IRMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
37.35-2.57 (-6.44%)
At close: 04:00PM EST
37.00 -0.35 (-0.94%)
After hours: 04:17PM EST
  • Dividend

    IRMD announced a cash dividend of 1.05 with an ex-date of Feb. 10, 2023

IRadimed Corporation

1025 Willa Springs Drive
Winter Springs, FL 32708
United States
407 677 8022

IndustryMedical Devices
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Roger E. SusiFounder, Chairman, CEO & Pres615.27kN/A1953
Mr. Randy WaddellVP of Worldwide Sales & Marketing482.73kN/AN/A
Mr. John F. GlennChief Financial OfficerN/AN/A1962
Mr. Chris WilliamsonExec. VP of Continuous Improvement & Information TechnologyN/AN/AN/A
Mr. Matt GarnerControllerN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

Corporate Governance

IRadimed Corporation’s ISS Governance QualityScore as of February 1, 2023 is 7. The pillar scores are Audit: 8; Board: 10; Shareholder Rights: 4; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.